InvestorsHub Logo
Followers 60
Posts 4078
Boards Moderated 0
Alias Born 04/23/2013

Re: RobinF post# 387703

Tuesday, 08/30/2022 12:40:19 PM

Tuesday, August 30, 2022 12:40:19 PM

Post# of 428910
In the course of the “Discovery” Phase of Amarin Vs. Hikma/Health Net, Amarin submitted a second Amended Identification of Asserted Claims (D.I. 135) that included DRL’s generic product as an “Accused/Product/Method.”

Meaning that if Health Net placed DRL’s product on a lower tier than branded VASCEPA®, it was inducing infringement just like doing the same for Hikma’s Product: Health Net objected to these additional claims and submitted a motion to “Strike” those claims:

https://drive.google.com/file/d/1lEnhUj08s1H4tT9UUkKJ737I9oD5zPAx/view?usp=sharing

Judge Hall’s new order: 08/30/2022 140 ORAL ORDER: “For the reasons stated at the August 29, 2022 teleconference, IT IS ORDERED that Health Net's Motion to Strike (D.I. 133 ) is DENIED.” ORDERED by Judge Jennifer L. Hall on 8/29/2022. (ceg) (Entered: 08/30/2022)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News